26/07/2021 Studies presented at AAIC show that reducing air pollution may benefit brain health and reduce dementia risk Science watch
22/07/2021 Results of Phase III HARMONY trial of pimavanserin for dementia-related psychosis have been published in the New England Journal of Medicine Science watch
19/07/2021 Systematic review & Meta-analysis provides estimates of Young-Onset Dementia highlighting that the condition affects almost 4 million worldwide Science watch
08/07/2021 New genomic atlas of proteins in the brain, CSF and plasma identifies potential new targets for AD treatment Science watch
08/07/2021 FDA updates the prescribing information for aducanumab, limiting it to people with MCI or mild AD Science watch
07/07/2021 Aducanumab and persons with Down Syndrome: what do we do now? NTG publishes Consensus statement on new drug following FDA approval Science watch
05/07/2021 TouchNEUROLOGY discusses REM Sleep Behaviour Disorder and Neurodegeneration with Professor Claudia Trenkwalder Science watch
02/07/2021 Alector and GSK announce collaboration to develop therapies for neurogenerative diseases Science watch
30/06/2021 Andrew Feigin discusses results from phase 2 Huntington’s disease trial of anti-semaphorin 4D antibody pepinemab (SIGNAL) Science watch
30/06/2021 Article on design and rationale of RECage study published in Journal of Alzheimer's Disease Science watch
30/06/2021 Article on design and rationale of RECage study published in Journal of Alzheimer's Disease Science watch
28/06/2021 Anavex Life Sciences announces that blarcamesine improved symptoms for people with Parkinson disease dementia Science watch
